LS Pharma SRL
2.8 FTEThe score of LS Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +62 % Total assets +23 % Headcount (avg FTE) +33 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LS Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Apr 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 07 Jun 2024
- Year ended 31 Dec 2022filed on 28 Mar 2023
LS Pharma's financial analysis
- Solvency74.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LS Pharma
LS Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0779.459.534
- VAT number
- BE0779459534
- Peppol
- Registered · 0208:0779459534 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 2021
- Registered office
- 5030 Gembloux
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2025 · filed on 13 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
LS Pharma (SRL) has been based in Gembloux since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 65,358 € and equity of 555,475 €; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 74.1%, above the median of its sector (41.5%).
Companies similar to LS Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Raes Retail sale of pharmaceutical products Ostend · balance sheet 744,652 €
- Pharmacie A-L Sprumont Retail sale of pharmaceutical products Namur · balance sheet 727,021 €
- Geassocieerde Apotheek Piot Retail sale of pharmaceutical products Antwerp · balance sheet 784,378 €
- Paques Pharma Retail sale of pharmaceutical products Profondeville · balance sheet 797,673 €
- Pharmaplus Detimmerman Retail sale of pharmaceutical products Tournai · balance sheet 803,004 €
- ViOph.arma Retail sale of pharmaceutical products Frameries · balance sheet 689,435 €
- Europa Apotheek Retail sale of pharmaceutical products Antwerp · balance sheet 819,025 €
- Kapelfarma Retail sale of pharmaceutical products Kontich · balance sheet 653,987 €
Frequently asked questions about LS Pharma
What is the revenue of LS Pharma?
LS Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LS Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0779459534 for LS Pharma, if the company is VAT-registered. Its company number (CBE) is 0779.459.534.
Where is the registered office of LS Pharma?
According to the CBE register, the registered office of LS Pharma is in 5030 Gembloux.
What is the equity of LS Pharma?
At the close of the 2025 financial year, the equity of LS Pharma amounts to 555,475 €, a solvency of 74.1% of total assets.
How many people work at LS Pharma?
2.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages LS Pharma?
The register lists 2 active mandates at LS Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LS Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →